Sign in
4

Changes in Ownership

Amylyx Pharmaceuticals, Inc. Filed Acc 0001193125-26-037553

Chief Financial Officer sold 3,557 shares at $14.65 ($52,097)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
FRATES JAMES M Chief Financial Officer 2026-02-02 Sale −3,557 $14.65 $52,097 173,547 D
Open-market sales · 3,557 sh · avg $14.65 · $52,097
Loading xslF345X05/ownership.xml…